Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance
Marta Sobas, Lars Bullinger(Stanford University), María Abáigar(Universidad de Salamanca), Laura Tur(GMV Innovating Solutions (Spain)), Alberto Hernández‐Sánchez, Eric Sträng(Humboldt-Universität zu Berlin), Jorge Sierra(Universitat Autònoma de Barcelona), Gastone Castellani(University of Bologna), Klaus H. Metzeler(University Hospital Leipzig), Javier Martínez Elicegui(Instituto de Investigación Biomédica de Salamanca), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Axel Benner(Memorial Sloan Kettering Cancer Center), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Jesús María Hernández‐Rivas(Universidad de Salamanca), Daniele Dall’Olio(University of Bologna), Torsten Haferlach(Martin Luther Christian University), Jesse M. Tettero(Amsterdam Neuroscience), Frédérik Damm(Humboldt-Universität zu Berlin), Renate Schulze‐Rath(Sanofi (France)), Konstanze Döhner(University Hospital Ulm), Amin T. Turki(University Hospitals of the Ruhr-University of Bochum), Rubén Villoria Medina(GMV Innovating Solutions (Spain)), Raúl Azibeiro Melchor(Universidad de Salamanca), Sören Lehmann(Uppsala University), Ángela Villaverde Ramiro(Instituto de Investigación Biomédica de Salamanca), Ken Mills(Johns Hopkins University), Dirk Reinhardt(Society of Paediatric Oncology and Haematology), Rosa Ayala(Hospital Universitario 12 De Octubre), Hartmut Döhner(University Hospital Ulm), Matteo Giovanni Della Porta(Humanitas University), Teresa González(Instituto de Investigación Biomédica de Salamanca), Gert J. Ossenkoppele(Dutch Cancer Society), Martje Barbus(AbbVie (Germany)), Jiří Mayer(Central European Institute of Technology), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 7
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k